Bariatric Arterial Embolization: Position Statement by the Pan Arab Interventional Radiology and the Saudi Interventional Radiology Societies

Mohammad Arabi; Karim A. Abd El Tawab; Mohammad Almoaiqe; Abbas Chamsuddin; Majed Ashour; Andrew J. Gunn; Ali Alzahrani

doi:10.4103/AJIR.AJIR_31_19

The Arab Journal of Interventional Radiology, Table of Contents

CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2020; 4(01): 04-10
DOI: 10.4103/AJIR.AJIR_31_19

Standards of Practice

Bariatric Arterial Embolization: Position Statement by the Pan Arab Interventional Radiology and the Saudi Interventional Radiology Societies

Authors

Mohammad Arabi

Department of Medical Imaging, Division of Vascular and Interventional Radiology, Ministry of National Guard Health Affairs, Saudi Arabia

King Abdullah International Medical Research Center, Saudi Arabia

King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Karim A. Abd El Tawab

Department of Radiology, Interventional Radiology Unit, Ain Shams University Hospitals, Cairo, Egypt
Mohammad Almoaiqe

Department of Medical Imaging, Division of Vascular and Interventional Radiology, Ministry of National Guard Health Affairs, Saudi Arabia

King Abdullah International Medical Research Center, Saudi Arabia

King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Abbas Chamsuddin

Department of Radiology, Division of Vascular and Interventional Radiology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
Majed Ashour

Department of Surgery, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
Andrew J. Gunn

Department of Radiology, Division of Vascular and Interventional Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Ali Alzahrani

King Abdullah International Medical Research Center, Saudi Arabia

King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

Department of Surgery, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

References
1 Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
2 UpToDate. Grading Guide. UpToDate. Grading Guide. Available from: https://www.uptodate.com/home/grading-guide#GradingRecommendations. [Last accessed on 2019 Nov 22].
3 Takahashi EA, Takahashi N, Reisenauer CJ, Moynagh MR, Misra S. Body composition changes after left gastric artery embolization in overweight and obese individuals. Abdom Radiol (NY) 2019;44:2627-31.
4 Bai ZB, Qin YL, Deng G, Zhao GF, Zhong BY, Teng GJ. Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients. Obes Surg 2018;28:907-15.
5 Weiss CR, Gunn AJ, Kim CY, Paxton BE, Kraitchman DL, Arepally A. Bariatric embolization of the gastric arteries for the treatment of obesity. J Vasc Interv Radiol 2015;26:613-24.
6 Arepally A, Barnett BP, Patel TH, Howland V, Boston RC, Kraitchman DL, et al. Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model. Radiology 2008;249:127-33.
7 Arepally A, Barnett BP, Montgomery E, Patel TH. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: Initial experience. Radiology 2007;244:138-43.
8 Weiss CR, Abiola GO, Fischman AM, Cheskin LJ, Vairavamurthy J, Holly BP, et al. Bariatric embolization of arteries for the treatment of obesity (BEAT Obesity) trial: Results at 1 year. Radiology 2019;291:792-800.
9 Weiss CR, Akinwande O, Paudel K, Cheskin LJ, Holly B, Hong K, et al. Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial. Radiology 2017;283:598-608.
10 Syed MI, Morar K, Shaikh A, Craig P, Khan O, Patel S, et al. Gastric artery embolization trial for the lessening of appetite nonsurgically (GET LEAN): Six-month preliminary data. J Vasc Interv Radiol 2016;27:1502-8.
11 Diana M, Pop R, Beaujeux R, Dallemagne B, Halvax P, Schlagowski I, et al. Embolization of arterial gastric supply in obesity (EMBARGO): An endovascular approach in the management of morbid obesity. Proof of the concept in the porcine model. Obes Surg 2015;25:550-8.
12 Word Health Organization. Prevalence of Obesity among Adults, Ages 18+, 1975-2016 (Age Standardized Estimate): Both Sexes, 2016. Word Health Organization; 2016.
13 AlMarri F, Al Sabah S, Al Haddad E, Vaz JD. A call for more research from the Arabian Gulf. Obes Surg 2017;27:2034-43.
14 Kim JM, Kim MD, Han K, Muqmiroh L, Kim SU, Kim GM, et al. Bariatric arterial embolization with non-spherical polyvinyl alcohol particles for ghrelin suppression in a swine model. Cardiovasc Intervent Radiol 2017;40:744-9.
15 Paxton BE, Arepally A, Alley CL, Kim CY. Bariatric embolization: Pilot study on the impact of gastroprotective agents and arterial distribution on ulceration risk and efficacy in a porcine model. J Vasc Interv Radiol 2016;27:1923-8.
16 Paxton BE, Alley CL, Crow JH, Burchette J, Weiss CR, Kraitchman DL, et al. Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model. J Vasc Interv Radiol 2014;25:455-61.
17 Paxton BE, Kim CY, Alley CL, Crow JH, Balmadrid B, Keith CG, et al. Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model. Radiology 2013;266:471-9.
18 Bawudun D, Xing Y, Liu WY, Huang YJ, Ren WX, Ma M, et al. Ghrelin suppression and fat loss after left gastric artery embolization in canine model. Cardiovasc Intervent Radiol 2012;35:1460-6.
19 Fu Y, Weiss CR, Paudel K, Shin EJ, Kedziorek D, Arepally A, et al. Bariatric arterial embolization: Effect of microsphere size on the suppression of fundal ghrelin expression and weight change in a swine model. Radiology 2018;289:83-9.
20 Diana M, Halvax P, Pop R, Schlagowski I, Bour G, Liu YY, et al. Gastric supply manipulation to modulate ghrelin production and enhance vascularization to the cardia: Proof of the concept in a porcine model. Surg Innov 2015;22:5-14.
21 Pasciak AS, Bourgeois AC, Paxton BE, Nodit L, Coan PN, Kraitchman D, et al. Bariatric radioembolization: A pilot study on technical feasibility and safety in a porcine model. J Vasc Interv Radiol 2016;27:1509-17.
22 Anton K, Rahman T, Bhanushali A, Patel AA. Bariatric left gastric artery embolization for the treatment of obesity: A review of gut hormone involvement in energy homeostasis. AJR Am J Roentgenol 2016;206:202-10.
23 Kim DJ, Raman HS, Salter A, Ramaswamy R, Gunn AJ, Weiss CR, et al. Analysis of weight changes after left gastric artery embolization in a cancer-naive population. Diagn Interv Radiol 2018;24:94-7.
24 Gunn AJ, Oklu R. A preliminary observation of weight loss following left gastric artery embolization in humans. J Obes 2014;2014:185349.
25 Kevin Anton TR, Bhanushali AB, Nadal LL, Pierce G, Patel AA. Weight loss following left gastric artery embolization in a human population without malignancy: A retrospective review. J Obesity Weight Loss Therapy 2015;5:285.
26 Kipshidze N, Archvadze A, Bertog S, Leon MB, Sievert H. Endovascular bariatrics:First in humans study of gastric artery embolization for weight loss. JACC Cardiovasc Interv 2015;8:1641-4.
27 Zaitoun MM, Basha MA, Hassan F, Elsayed SB, Farag AA, Amer M, et al. Left gastric artery embolization in obese, prediabetic patients: A pilot study. J Vasc Interv Radiol 2019;30:790-6.
28 Elens S, Roger T, Elens M, Rommens J, Sarafidis A, Capelluto E, et al. Gastric embolization as treatment for overweight patients; efficacy and safety. Cardiovasc Intervent Radiol 2019;42:513-9.
29 Hafezi-Nejad N, Bailey CR, Gunn AJ, Weiss CR. Weight loss after left gastric artery embolization: A systematic review and meta-analysis. J Vasc Interv Radiol 2019;30:1593-603.
30 Pirlet C, Ruzsa Z, Costerousse O, Nemes B, Merkely B, Poirier P, et al. Transradial left gastric artery embolization to treat severe obesity: A pilot study. Catheter Cardiovasc Interv 2019;93:365-70.
31 Salsamendi J, Pereira K, Kang K, Fan J. Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): A case report. J Radiol Case Rep 2015;9:36-43.
32 Fink JM, Martini V, Seifert G, Marjanovic G. Left gastric artery embolization for weight loss-a dead-end procedure. Obes Surg 2018;28:3623-4.
33 Kordzadeh A, Lorenzi B, Hanif MA, Charalabopoulos A. Left gastric artery embolisation for the treatment of obesity: A systematic review. Obes Surg 2018;28:1797-802.
34 Hibbert B, Simard T, Wilson KR, Hawken S, Wells GA, Ramirez FD, et al. Transradial versus transfemoral artery approach for coronary angiography and percutaneous coronary intervention in the extremely obese. JACC Cardiovasc Interv 2012;5:819-26.
35 Byrne J, Spence MS, Fretz E, Mildenberger R, Chase A, Berry B, et al. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). Am J Cardiol 2009;103:507-11.
36 Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol 2004;94:1174-7.
37 Hung ML, Lee EW, McWilliams JP, Padia SA, Ding P, Kee ST. A reality check in transradial access: A single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention. Eur Radiol 2019;29:68-74.
38 Yamada R, Bracewell S, Bassaco B, Camacho J, Anderson MB, Conrad A, et al. Transradial versus transfemoral arterial access in liver cancer embolization: Randomized trial to assess patient satisfaction. J Vasc Interv Radiol 2018;29:38-43.